Back to top

Edgewise’s EDG-15400 Phase 1 Milestone: What It Means for EWTX Investors

Edgewise Therapeutics, Inc. ($EWTX) announced an update on their ongoing clinical study. Edgewise Therapeutics, Inc. is running a Phase 1 study cal...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Edgewise Therapeutics, Inc. (EWTX)